EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 19 / No 3 (Mars 2003) Med Sci (Paris), 19 3 (2003) 319-326 References
Free Access
Issue
Med Sci (Paris)
Volume 19, Number 3, Mars 2003
Page(s) 319 - 326
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2003193319
Published online 15 March 2003
  1. Gergen PJ. Understanding the economic burden of asthma. J Allergy Clin Immunol 2001; 107: S445–8. [Google Scholar]
  2. Neukirch F, Pin I, Knani J, et al. Prevalence of asthma and asthma-like symptoms in three French cities. Respir Med 1995; 89: 685–92. [Google Scholar]
  3. Guidelines for the Diagnosis and Management of Asthma. Expert Panareport 2. Atlanta, Ga: National Institute of Health, May 1997. National Heart, Lung and Blood Institute Publication n° 97–4051A. [Google Scholar]
  4. Djukanovic R, Roche WR, Wilson JW, Beasley CRW, Twentyman OP, Howarth PH. Mucosal inflammation in asthma. Am Rev Respir Dis 1990; 142: 434–57. [Google Scholar]
  5. Barnes PJ. Mechanisms of action of glucocorticoids in asthma. Am J Respir Crit Care Med 1996; 154: 21–7. [Google Scholar]
  6. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15- year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339: 1194–200. [Google Scholar]
  7. Chung KF, Godard P. ERS task force: difficult therapyresistant asthma. Eur Respir J 1999; 13: 1198–208. [Google Scholar]
  8. Elias JA, Zhu Z, Chupp G, Homer RJ. Airway remodeling in asthma. J Clin Invest 1999; 104: 1001–6. [Google Scholar]
  9. Bousquet J, Jeffery P, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000; 161: 1720–45. [Google Scholar]
  10. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000; 343: 269–80. [Google Scholar]
  11. Jeffery PK. Remodeling in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: S28–38. [Google Scholar]
  12. Vignola AM, Chiappara G, Gagliardo R, et al. Apoptosis and airway inflammation in asthma. Apoptosis 2000; 5: 473–85. [Google Scholar]
  13. Druilhe A, Létuvé S, Pretolani M. Eosinophil apoptosis in asthma. Pathol Biol 2000; 48: 566–73. [Google Scholar]
  14. Pretolani M. Remodeling of the respiratory tract in asthma. Biological factors and potential physiopathological implications in the apoptosis process. Rev Mal Respir 1999; 16: S27–8. [Google Scholar]
  15. Anderson JM. Molecular structure of tight junctions and their role in epithelial transport. News Physiol Sci 2001; 16: 126–30. [Google Scholar]
  16. Nievers MG, Schaapveld RQ, Sonnenberg A. Biology and function of hemidesmosomes. Matrix Biol 1999; 18:5–17. [Google Scholar]
  17. Holgate ST, Davies DE, Lackie PM, Wilson SJ, Puddicombe SM, Lordan JL. Epithelial-mesenchymal interactions in the pathogenesis of asthma. Eur Respir J 2000; 105: 193–204. [Google Scholar]
  18. Davies DE, Polosa R, Puddicombe SM, Richter A, Holgate ST. The epidermal growth factor receptor and its ligand family: their potential role in repair and remodelling in asthma. Allergy 1999; 54: 771–83. [Google Scholar]
  19. Thompson AB, Robbins RA, Romberger DJ, et al. Immunological functions of the pulmonary epithelium. Eur Respir J 1995; 8: 127–49 [Google Scholar]
  20. Waters CM, Savla U. Keratinocyte growth factor accelerates wound closure in airway epithelium during cyclic mechanical strain. J Cell Physiol 1999; 181: 424–32. [Google Scholar]
  21. Takeoka M, Ward WF, Pollack H, Kamp DW, Panos RJ. KGF facilitates repair of radiation-induced DNA damage in alveolar epithelial cells. Am J Physiol 1997; 272: L1174–80. [Google Scholar]
  22. Okada-Ban M, Thiery JP, Jouanneau J. Fibroblast growth factor-2. Int J Biochem Cell Biol 2000; 32: 263–7. [Google Scholar]
  23. Carpenter G, Wahl MI. The epidermal growth factor family. In: Sporn MB, Roberts AB, eds. Peptide growth factors and their receptors. New York: Springer-Verlag, 1991 : 69–171. [Google Scholar]
  24. Puddicombe SM, Polosa R, Richter A, et al. Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J 2000; 14: 1362–74. [Google Scholar]
  25. Warburton D, Schwarz M, Tefft D, Flores-Delgado G, Anderson KD, Cardoso WV. The molecular basis of lung morphogenesis. Mech Dev 2000; 92: 55–81. [Google Scholar]
  26. Johnson P, Maiti A, Brown KL, Li R. A role for the cell adhesion molecule CD44 and sulfation in leukocyteendothelial cell adhesion during an inflammatory response? Biochem Pharmacol 2000; 59: 455–65. [Google Scholar]
  27. Ilyas M, Tomlison IP. The interactions of APC, Ecadherin and β-catenin in tumour development and progression. J Pathol 1997; 182: 128–37. [Google Scholar]
  28. Kikuchi A. Regulation of β- catenin signaling in the Wnt pathway. Biochem Biophys Res Commun 2000; 268: 243–8. [Google Scholar]
  29. Stockinger A, Eger A, Wolf J, Beug H, Foisner R. Ecadherin regulates cell growth by modulating proliferation-dependent β- catenin transcriptional activity. J Cell Biol 2001; 154: 1185–96. [Google Scholar]
  30. Goto Y, Uchida Y, Nomura A, et al. Dislocation of Ecadherin in the airways epithelium during an antigen-induced asthmatic response. Am J Respir Cell Mol Biol 2000; 23: 712–8. [Google Scholar]
  31. Carayol N, Campbell A, Vachier I, et al. Modulation of cadherin and catenin expression by tumor necrosis factor-α and dexamethasone in human bronchial epithelial cells. Am J Respir Cell Mol Biol 2002; 26: 341–7. [Google Scholar]
  32. Hirst SJ, Walker TR, Chilvers ER. Phenotypic diversity and molecular mechanisms of airway smooth proliferation in asthma. Eur Respir J 2000; 16: 159–77. [Google Scholar]
  33. Aikawa M, Palanisamy NS, Kuro-o M, et al. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circ Res 1993; 73: 1000–12. [Google Scholar]
  34. Liu X, Shao Q, Dhalla NS. Myosin light chain phosphorylation in cardiac hypertrophy and failure due to myocardial infarction. J Mol Cell Cardiol 1995; 27: 2613–21. [Google Scholar]
  35. McKay S, de Jongste JC, Saxena PR, Sharma HS. Angiotensin II induces hypertrophy of human airway smooth muscle cells: expression of transcription factors and transforming growth factor-β1. Am J Respir Cell Mol Biol 1998; 18: 823–33. [Google Scholar]
  36. Panettieri RA, Murray RK, Eszterhs AJ, Bilgen G, Martin JG. Repeated allergen inhalations induce DNA synthesis in airway smooth muscle and epithelial cells in vivo. Am J Physiol Lung Cell Mol Physiol 1998; 274: L417–24. [Google Scholar]
  37. Corrigan CJ, Brown PH, Barnes NC, et al. Glucocorticoid resistance in chronic asthma glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheralblood T-cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis 1991; 144: 1016–25. [Google Scholar]
  38. Adcock IM, Lane SJ, Brown CR, Peters MJ, Lee TH, Barnes PJ. Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma. J Immunol 1995; 154: 3500–5. [Google Scholar]
  39. Spector SL. Treatment of the unusually difficult asthmatic patients. Allergy Asthma Proc 1997; 18: 153–5. [Google Scholar]
  40. Barnes PJ. Anti-IgE antibody therapy for asthma. N Engl J Med 1999; 341: 2006–8. [Google Scholar]
  41. Barnes PJ. Endothelins and pulmonary diseases. J Appl Physiol 1994; 77: 1051–9. [Google Scholar]
  42. Panettieri RA, Goldie RG, Rigby PJ, Eszterhas AJ, Hay DW. Endothelin-1-induced potentiation of human airway smooth muscle proliferation: an ETA receptor-mediated phenomenon. Br J Pharmacol 1996; 118: 191–7. [Google Scholar]
  43. Burnouf C, Pruniaux MP. Recent advances in PDE4 inhibitors as immunoregulators and antiinflammatory drugs. Curr Pharmaceutical Des 2002; 8: 1255–96. [Google Scholar]
  44. Kohyama T, Liu XD, Zhu YK, et al. Phosphodiesterase inhibitor Cilomast inhibits fibroblasts-mediated collagen gel degradation induced by tumor necrosis factor-α. Am J Respir Cell Mol Biol 2002; 27: 487–94. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.